Insights

Strong Market Presence Ultragenyx operates in the highly specialized biotech sector focusing on rare and ultrarare genetic diseases, with substantial revenue between $250M and $500M and a robust pipeline of approved therapies. This indicates significant market penetration and opportunities to expand further through partnerships or targeted product collaborations.

Pipeline and Product Portfolio The company boasts a diverse and growing clinical pipeline alongside flagship products like Crysvita and Dojolvi, generating hundreds of millions in revenue. Collaborating with Ultragenyx on clinical trial support, distribution, or manufacturing can unlock value in their innovative therapies and emerging pipeline.

Focus on Rare Diseases Ultragenyx’s dedicated focus on rare and genetic diseases with high unmet medical needs positions it as a key partner for specialized service providers, including contract research organizations, biotech tech platforms, and supply chain solutions tailored for complex therapies.

Recent Legal and Financial Activity Frequent news around class action lawsuits and financial updates suggest some volatility, providing opportunities for risk management and compliance solutions, as well as financial services that help strengthen stakeholder confidence and operational resilience.

Tech and Data Utilization Ultragenyx employs advanced technology stacks such as AWS, Power BI, and SAP solutions, indicating a readiness for digital transformation initiatives. Offering innovative data analytics, cloud services, or IT infrastructure support can help streamline their development and commercialization efforts.

Ultragenyx Tech Stack

Ultragenyx uses 8 technology products and services including Adobe, Power BI, SAP Crystal Solutions, and more. Explore Ultragenyx's tech stack below.

  • Adobe
    Audio, Video, Graphics
  • Power BI
    Business Intelligence
  • SAP Crystal Solutions
    Business Intelligence
  • Amazon Web Services
    Cloud Hosting
  • Microsoft Outlook
    Email
  • Oracle E-Business Suite
    Enterprise Resource Planning
  • SailPoint
    Identity And Access Management
  • Cisco
    Network Hardware

Media & News

Ultragenyx's Email Address Formats

Ultragenyx uses at least 1 format(s):
Ultragenyx Email FormatsExamplePercentage
FLast@ultragenyx.comJDoe@ultragenyx.com
94%
FiLast@ultragenyx.comJoDoe@ultragenyx.com
4%
LFirst@ultragenyx.comDJohn@ultragenyx.com
1%
FirstLast@ultragenyx.comJohnDoe@ultragenyx.com
1%

Frequently Asked Questions

Where is Ultragenyx's headquarters located?

Minus sign iconPlus sign icon
Ultragenyx's main headquarters is located at 60 Leveroni Court Novato, California 94949 United States. The company has employees across 5 continents, including North AmericaEuropeSouth America.

What is Ultragenyx's phone number?

Minus sign iconPlus sign icon
You can contact Ultragenyx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ultragenyx's stock symbol?

Minus sign iconPlus sign icon
Ultragenyx is a publicly traded company; the company's stock symbol is RARE.

What is Ultragenyx's official website and social media links?

Minus sign iconPlus sign icon
Ultragenyx's official website is ultragenyx.com and has social profiles on LinkedIn.

What is Ultragenyx's SIC code NAICS code?

Minus sign iconPlus sign icon
Ultragenyx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ultragenyx have currently?

Minus sign iconPlus sign icon
As of February 2026, Ultragenyx has approximately 1.6K employees across 5 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: J. R.Chief Medical Officer And Executive Vice President: E. C.Chief Accounting Officer (cao), Svp: T. H.. Explore Ultragenyx's employee directory with LeadIQ.

What industry does Ultragenyx belong to?

Minus sign iconPlus sign icon
Ultragenyx operates in the Biotechnology Research industry.

What technology does Ultragenyx use?

Minus sign iconPlus sign icon
Ultragenyx's tech stack includes AdobePower BISAP Crystal SolutionsAmazon Web ServicesMicrosoft OutlookOracle E-Business SuiteSailPointCisco.

What is Ultragenyx's email format?

Minus sign iconPlus sign icon
Ultragenyx's email format typically follows the pattern of FLast@ultragenyx.com. Find more Ultragenyx email formats with LeadIQ.

When was Ultragenyx founded?

Minus sign iconPlus sign icon
Ultragenyx was founded in 2010.

Ultragenyx

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Leading with purpose. Every day.

“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.”

Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President


We have an inclusive culture of value and respect.

Ultragenyx brings novel products to those living with rare and ultrarare diseases with a focus on debilitating genetic diseases. Founded in 2010, we have rapidly built a diverse portfolio of approved therapies and products aimed at diseases with a high unmet medical need for which many have no approved therapies. It takes courage, care, talent, and dedication to make a meaningful impact for those living with rare diseases, their families and the rare disease community.  

We put our people first, so they can take care of the rare disease community.

We purposefully cultivate and nurture a dynamic, supportive work environment where we encourage every team member to share their new ideas and help us unlock more possibilities. Our team is made up of exceptional and diverse people with a strong passion and commitment to helping those living with rare diseases. By embracing generosity, curiosity, inclusion, and humility we are constantly learning together—fostering an environment that supports profound growth and fulfillment.

If you want to have a meaningful impact, do the best work of your career while having fun and growing professionally and personally, come join our team!


Visit our community guidelines at: https://ultragenyx.co/community

Section iconCompany Overview

Headquarters
60 Leveroni Court Novato, California 94949 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RARE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
1001-5000

Section iconFunding & Financials

  • $250M$500M

    Ultragenyx's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Ultragenyx's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.